Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
Costa RicaIPO:
19 July 2018Website:
http://www.establishmentlabs.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 6 min agoDividend
Analysts recommendations
Institutional Ownership
ESTA Latest News
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Rajbir Denhoy - Chief Financial Officer Juan Jose - CEO and Founder Conference Call Participants Allen Gong - JPMorgan Matt Taylor - Jefferies Sam Eiber - BTIG Anthony Pettinari - Citi Josh Jennings - TD Cowen Anthony Petrone - Mizuho Group Operator Good afternoon. Welcome to Establishment Labs Third Quarter 2024 Earnings Conference Call.
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $1.12 per share a year ago.
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with select purchasers for the purchase of 765,696 common shares and pre-funded warrants to purchase up to 328,161 common shares in a registered direct offering for a.
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round breast implants in primary and revision breast augmentation. “Today's approval is transformative for breast aesthetics in.
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.65 per share a year ago.
Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.95. This compares to loss of $0.55 per share a year ago.
Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Establishment Labs missed consensus revenue and earnings estimates in Q3. The company also slashed its full-year guidance.
What type of business is Establishment Labs Holdings?
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
What sector is Establishment Labs Holdings in?
Establishment Labs Holdings is in the Healthcare sector
What industry is Establishment Labs Holdings in?
Establishment Labs Holdings is in the Medical Devices industry
What country is Establishment Labs Holdings from?
Establishment Labs Holdings is headquartered in Costa Rica
When did Establishment Labs Holdings go public?
Establishment Labs Holdings initial public offering (IPO) was on 19 July 2018
What is Establishment Labs Holdings website?
https://www.establishmentlabs.com
Is Establishment Labs Holdings in the S&P 500?
No, Establishment Labs Holdings is not included in the S&P 500 index
Is Establishment Labs Holdings in the NASDAQ 100?
No, Establishment Labs Holdings is not included in the NASDAQ 100 index
Is Establishment Labs Holdings in the Dow Jones?
No, Establishment Labs Holdings is not included in the Dow Jones index
When was Establishment Labs Holdings the previous earnings report?
No data
When does Establishment Labs Holdings earnings report?
The next expected earnings date for Establishment Labs Holdings is 28 February 2025